.
MDS UK ANNUAL GENERAL MEETING
All registered MDS UK members are welcome to attend.
When: Friday 4th December 2020, 11:30 am
Where: Virtual Zoom Meeting
Register in advance for this meeting by clicking on this link:
https://us02web.zoom.us/meeting/registe ... 8PkIgizqHO
After registering, you will receive a confirmation email containing information about joining the meeting.
AGENDA
1) Introduction
Speaker: Kent Group Coordinator and Interim Chair - Andy Veitch
2) Apologies for absence
3) Report of the Trustees for year ended 31/03/2020
Speaker: Chief Executive and Trustee – Sophie Wintrich
Activity report
4) Adoption of Accounts – year ended 31/03/2020
Speaker: Treasurer Trustee – Don Barrett
Proposal
Secondment
5) MDS Animation – ‘Myelo’s Hope’
Speaker: Deputy Chair Trustee – Russell Cook
6) Any Other Business
Activity report, accounts and Examiner’s report – copies available on request
MDS UK Main Office - 0207 733 7558 - info@mdspatientsupport.org.uk
.
1130am - Fri 4th Dec 2020 - MDS UK Annual General Meeting
Moderator: Steering Committee
-
- Posts: 15
- Joined: 05 Nov 2018 09:54
- Contact:
1130am - Fri 4th Dec 2020 - MDS UK Annual General Meeting
Andy Veitch.
MDS Patient and MDS UK Local Group Coordinator for Kent.
2018, October: Diagnosed (aged 54) with MDS-MLD (was MDS-RCMD).
Haemoglobin and Neutrophils both affected.
Chromosome gain +1q21, and genetic mutations ASXL1 and U2AF1 identified.
MDS Patient and MDS UK Local Group Coordinator for Kent.
2018, October: Diagnosed (aged 54) with MDS-MLD (was MDS-RCMD).
Haemoglobin and Neutrophils both affected.
Chromosome gain +1q21, and genetic mutations ASXL1 and U2AF1 identified.
-
- Posts: 15
- Joined: 05 Nov 2018 09:54
- Contact:
Re: 1130am - Fri 4th Dec 2020 - MDS UK Annual General Meeting
Just a quick extra word about this Zoom meeting, it is the Annual General Meeting, a formality to present matters appertaining to the operation of the charity as per the agenda, and is not in any way a patient support meeting.
Andy Veitch.
MDS Patient and MDS UK Local Group Coordinator for Kent.
2018, October: Diagnosed (aged 54) with MDS-MLD (was MDS-RCMD).
Haemoglobin and Neutrophils both affected.
Chromosome gain +1q21, and genetic mutations ASXL1 and U2AF1 identified.
MDS Patient and MDS UK Local Group Coordinator for Kent.
2018, October: Diagnosed (aged 54) with MDS-MLD (was MDS-RCMD).
Haemoglobin and Neutrophils both affected.
Chromosome gain +1q21, and genetic mutations ASXL1 and U2AF1 identified.
Who is online
Users browsing this forum: No registered users and 3 guests